Press release
Non-Hodgkin Lymphoma Market Size, Share, Industry, Forecast and outlook (2023-2030)
The global Non-Hodgkin Lymphoma (NHL) Market, valued at USD 7.3 billion in 2022, is anticipated to grow significantly, reaching USD 13.5 billion by 2030, exhibiting a projected Compound Annual Growth Rate (CAGR) of 8.2% from 2023 to 2030. NHL, a type of cancer originating in the lymphatic system, involves abnormal lymphocyte growth, impacting the body's immune system. It comprises diverse lymphomas, each with unique characteristics and treatment methods.Treatment for NHL varies based on subtype, disease stage, and patient-specific factors, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplantation. The goal is remission induction, symptom alleviation, and extended survival, often personalized to individual needs.
Market Scope:
CAGR: 8.2%
Forecast Period: 2023-2030
Segments Covered: Disease Type, Drug Class, Route of Administration, Distribution Channel, Region
Regions Covered: North America, Europe, Asia-Pacific, South America, Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Insights Covered: Competitive Landscape, Company Profiles, Market Size, Share, Growth, Demand, Recent Developments, Mergers & Acquisitions, New Product Launches, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other Key Insights.
Request for Free Sample: https://www.datamintelligence.com/download-sample/non-hodgkin-lymphoma-market
Market Dynamics:
Regulatory approvals for NHL treatments, such as China's conditional approval of AstraZeneca's Calquence for mantle cell lymphoma, and the increasing clinical trials for NHL drugs, exemplified by studies like the Abramson Cancer Center's Phase II trial evaluating RADVAX, drive market growth. However, limited targeted therapies for certain NHL subtypes pose challenges.
Segment Analysis:
B-cell lymphomas hold approximately 52.6% of the market share, with increasing prevalence and rising clinical trials driving demand. Diffuse Large B-cell Lymphoma (DLBCL) is the most prevalent NHL subtype globally.
Geographical Share:
North America accounted for 41.9% market share in 2022, primarily due to research, robust healthcare infrastructure, and emphasis on targeted therapies and immunotherapy for NHL.
Market Companies:
Key players include AbbVie, AstraZeneca, Bayer AG, Bristol-Myers Squibb, Gilead Sciences, Johnson & Johnson, Merck & Co., Novartis AG, Roche Holding AG, Seagen, Takeda Pharmaceutical, and Teva Pharmaceutical.
Russia-Ukraine War Impact and Key Developments:
The Russia-Ukraine conflict moderately affects the NHL market, disrupting healthcare infrastructure, limiting access to care, and hindering data collection and research efforts in affected regions.
Notable developments include FDA approvals for Genentech's Lunsumio and Loxo Lilly's Jaypirca, and FDA review for Genentech's glofitamab, all advancing treatments for various NHL subtypes.
This revised content integrates essential keywords, highlighting critical facets of the Non-Hodgkin Lymphoma market and its anticipated growth factors and challenges.
Related Reports:
https://www.datamintelligence.com/download-sample/t-cell-lymphoma-market
https://www.datamintelligence.com/download-sample/hodgkin-lymphoma-market
https://www.datamintelligence.com/download-sample/mantle-cell-lymphoma-market
Media Contact
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/
About DataM Intelligence
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Hodgkin Lymphoma Market Size, Share, Industry, Forecast and outlook (2023-2030) here
News-ID: 3303863 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Horseradish Peroxidase Market Surges at 7.2% CAGR Led by Bio-Rad L …
Leander, Texas and TOKYO, Japan - Dec. 02, 2025. According to DataM Intelligence, the United States Horseradish Peroxidase Market Size is growing from USD 22.5 million in 2023 to USD 39 million by 2031, registering a robust CAGR of 7.2% during 2024-2031. The surging demand for advanced diagnostic tools, the expansion of immunoassay kits, and breakthroughs in recombinant enzyme production are fueling the need for enhanced HRP formulations that maximise…
Frozen Fruits Market Surges Toward US$6.54 Billion by 2030 - Asia-Pacific Leads …
According to DataM Intelligence, the global frozen fruits market size was valued at US$3,957.4 million in 2022 and is forecasted to reach US$6,549.4 million by 2030, growing at a CAGR of 6.5% from 2024 to 2031. This steady growth is propelled by rising health consciousness among consumers, increasing demand for convenient and nutritious food options, expanding food processing and service sectors, growing preference for organic and plant-based products, surging popularity…
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates …
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus on…
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo …
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, and…
More Releases for NHL
Jeane Marie Leads National Campaign to Demand NHL Accountability on Domestic Vio …
LOS ANGELES, CA - While many know Jeane Marieas a Billboard-charting artist featured in Daily Mail, Good Morning America, The Today Show, and Yahoo, few know she's also a survivor of domestic abuse. Today, she's leading a movement to demand change from one of the most powerful sports institutions in North America: the National Hockey League (NHL).
Her campaign, No Glory for Abusers, challenges the NHL's refusal to adopt a…
Non Hodgkin Lymphoma (NHL) Market 2024-2033: Trends, Growth & Analysis Forecast
The non hodgkin lymphoma (nhl) market size has grown strongly in recent years. It will grow from $9.34 billion in 2023 to $10.23 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased incidence of nhl, advancements in diagnostics, chemotherapy and immunotherapy, clinical research and drug development, improved survival rates.
The non hodgkin lymphoma (nhl) market…
Non Hodgkin Lymphoma (NHL) Market 2021 | Detailed Report
The Non Hodgkin Lymphoma (NHL) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players.Furthermore, the report offers insightful market data and information about the Non…
Global Natural Hydraulic Lime (NHL) Market Sales Data Analysis 2020-2025
Market Overview
The Natural Hydraulic Lime (NHL) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Natural Hydraulic Lime (NHL) market size is expected to gain market growth in the forecast…
Natural Hydraulic Lime (NHL) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Natural Hydraulic Lime (NHL) market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Natural Hydraulic Lime (NHL)market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Natural Hydraulic Lime (NHL)market, market definition,…
Global Forecast Of Epidemiology Of Non-Hodgkins Lymphoma (NHL) Till 2023
Researchmoz added Most up-to-date research on " Global Forecast Of Epidemiology Of Non-Hodgkins Lymphoma (NHL) Till 2023" to its huge collection of research reports.
DelveInsights Non-Hodgkins Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Non-Hodgkins Lymphoma (NHL) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the…
